---
title: "Travere Therapeutics (TVTX.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/TVTX.US/norm.md"
symbol: "TVTX.US"
name: "Travere Therapeutics"
parent: "https://longbridge.com/zh-CN/quote/TVTX.US.md"
datetime: "2026-03-16T06:32:43.802Z"
locales:
  - [en](https://longbridge.com/en/quote/TVTX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TVTX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TVTX.US/norm.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/TVTX.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/TVTX.US/norm.md)


# Travere Therapeutics (TVTX.US) — 财务报表

## 利润表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.0302 | 0.2754 | -0.1434 | -0.4666 | -0.7258 |
| ROE | -93.36% | 193.44% | -155.62% | -358.88% | -1684.46% |
| Revenue | 129.69M | 164.86M | 114.45M | 81.73M | 74.79M |
| Net income | 2.73M | 25.71M | -12.76M | -41.23M | -60.26M |
| Operating income | -32.43M | 24.93M | -12.65M | -42.67M | -59.33M |
| Gross margin | 53.41% | 67.56% | 55.54% | 36.91% | 13.59% |
| Net margin | 2.10% | 15.59% | -11.14% | -50.44% | -80.58% |
| Profit quality | -53.44% | 174.14% | -253.86% | - | - |

## 资产负债表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 605.19M | 538.58M | 555.31M | 548.80M | 594.13M |
| Leverage | 5.27 | 7.32 | 16.96 | 16.72 | 10.06 |
| BVPS | 1.26 | 0.8223 | 0.3675 | 0.3697 | 0.6755 |
| Turnover | 0.8183 | 0.8357 | 0.6035 | 0.4512 | 0.3372 |
| Cash & STI | 322.80M | 254.53M | 319.54M | 322.24M | 370.70M |
| Inv & Rec | 5.88M | 5.55M | 4.09M | 3.93M | 6.20M |
| LT assets | 14.60M | 15.78M | 16.90M | 18.05M | 19.63M |
| Net debt | 5.94M | 75.22M | 80.04M | 78.22M | 30.88M |

## 现金流量表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 60.68M | 14.32M | 4.98M | -42.19M | -35.72M |
| Investing CF | -104.84M | 86.59M | 4.85M | 41.29M | -80.31M |
| Financing CF | 26.68M | -65.34M | 1.48M | 3.72M | 139.12M |
| Free CF | 16.97M | -14.87M | 3.20M | -38.52M | -13.51M |
| OCF coverage | -16180.80% | 20.74% | 2120.43% | - | 43560.98% |
| Repaid & issued | - | - | - | - | - |
| CapEx | 375000.00 | -140000.00 | -235000.00 | - | 82000.00 |